Exelixis
EXEL
#1773
Rank
ยฃ7.63 B
Marketcap
ยฃ26.74
Share price
0.67%
Change (1 day)
56.70%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company